Revance Therapeutics, Inc. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- Offer Letter dated February 21, 2023 by and between Revance Therapeutics, Inc. and Erica Jordan (Filed With SEC on May 9, 2024)
- Offer Letter dated September 29, 2022 by and between Revance Therapeutics, Inc. and David Hollander, MD (Filed With SEC on May 9, 2024)
- Revance Therapeutics, Inc. 202 (Filed With SEC on February 28, 2024)
- Description of Registrants Securities (Filed With SEC on February 28, 2024)
- Revance Therapeutics, Inc. 202 (Filed With SEC on February 28, 2023)
- Description of Registrants Securities (Filed With SEC on February 28, 2023)
- Description of Registrants Securities (Filed With SEC on February 28, 2022)
- Description of Registrants Securities (Filed With SEC on February 25, 2021)
- Revance Therapeutics, Inc. Amended and Restated 2014 Inducement Plan (Filed With SEC on November 9, 2020)
- Form of Lock-Up Agreement by and between Revance Therapeutics, Inc. and each of the parties named in each agreement therein (Filed With SEC on June 10, 2020)
- Description of Registrants Securities (Filed With SEC on February 26, 2020)
- Appendix A (Filed With SEC on May 14, 2015)
- Appendix A (Filed With SEC on June 16, 2014)
- INDEMNITY AGREEMENT [For Officers and Directors Not Affiliated withFunds] (Filed With SEC on January 27, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on December 31, 2013)
